PM10from Mexico City (MC) induce senescence-like phenotype and ATM, γH2A.X and p53 activation linked to oxidative stress
© Sánchez-Pérez et al; licensee BioMed Central Ltd. 2007
Published: 5 February 2007
Urban air particulate matter (PM) relates to adverse health effects including lung cancer. Previous work from our group demonstrated that the PM10 produce DNA damage, although the mechanisms involved are not known. DNA double-strand breaks (DSBs) are the most deleterious DNA lesions. DSBs arise from exogenous agents such as metals and hydrocarbons, or endogenous agents, such as reactive oxygen species (ROS). We explore the cellular response that senses DNA damage after cell exposure to PM10, evaluating markers such as phosphorylation of ATM (ser1981), γH2A.X (ser139) and p53 (ser15), and senescence-like induction, as well as the identification of ROS co-participation in the response.
Materials and methods
A549 cells were exposed 24 h to 10 μg/cm2 of PM10 from an urban-commercial zone from MC. ROS induction was evaluated by DCFH-DA assay. Senescence was determined by the β-galactosidase assay. ATM, γH2A.X and p53 activation and their co-localization on DNA damage foci were done by immunofluorescence. Experiments in the presence of Trolox as an OH· scavenger were done in parallel.
Senescence-like was induced by PM10. ATM, H2A.X and p53 were activated by PM10 and co-localize in DNA damage foci. Both cellular responses were prevented by Trolox.
Cells exposed to PM10 had a cellular response directly involved in sensing DSBs. There was a strong co-relation with the presence of ROS that suggests the participation of oxidative stress in the deleterious effects induced by PM10. Senescence-like phenotype and ATM, γH2A.X and p53 activation conform an early cellular response that could evolve into the signaling and recruitment of repair factors, and the activation of enzymes of cell cycle checkpoints in cells exposed to PM10. Further studies must be done to confirm that.
Parker B. Francis Fellowship, CONACyT 43138-M
This article is published under license to BioMed Central Ltd.